Controlling Herpes Simplex Virus Infections: is Intracellular Immunization the Way of the Future?

  • K. K. WongJr.
  • S. Chatterjee
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 179)


The available approaches to the management of herpes simplex virus (HSV) infections currently consist primarily of chemotherapy and the possibility of preventive vaccination. In this review, we explore the potential of a third approach based on recent advances in molecular biology and genetic engineering which renders cells resistant to viral infection. This form of antiviral gene therapy, termed “intracellular immunization” by Baltimore (1988), involves the intracellular expression of a variety of molecular species specifically designed to inhibit targeted virus replication. The utility of such an approach lies in the direct application of knowledge pertaining to molecular mechanisms involved in viral pathogenesis to precisely interrupt lytic infection through the generation of virus-resistant cells. Such strategies may be particularly useful in the management of intracel-lular pathogens which are capable of evading the immune system or in circumstances in which knowledge of molecular pathogenic mechanisms far surpasses the ability to develop appropriate therapeutic drugs or vaccines. In this article, the basic concepts of intracellular immunization, relevant aspects of HSV molecular biology, and studies utilizing antiviral gene therapy to prevent HSV infection will be reviewed.


Human Immunodeficiency Virus Human Immunodeficiency Virus Type Herpes Simplex Virus Type Ribonucleotide Reductase Herpes Simplex Virus Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen ND, Cran DG, Barton SC, Hettle S, Reik R, Surani MAH (1988) Transgenes as probes for active chromosomal domains in mouse development. Nature 333: 852–855PubMedCrossRefGoogle Scholar
  2. Anderson WF (1984) Prospects for human gene therapy. Science 226: 401–409PubMedCrossRefGoogle Scholar
  3. Andreason GL, Evans GA (1988) Introduction and expression of DNA moleculesin eukaryotic cells by electroporation. BioTechniques 6: 650–660PubMedGoogle Scholar
  4. Anheiter H, Skuntz S, Noteborn M, Chang S, Meier E (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62: 51–61CrossRefGoogle Scholar
  5. Baltimore D (1988) Intracellular immunization. Nature 335: 395–396PubMedCrossRefGoogle Scholar
  6. Bass BL, Weintraub H (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55:1089–1098PubMedCrossRefGoogle Scholar
  7. Bednarik DP, Mosca JD, Raj NBK, Pitha PM (1989) Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha-2 interferon. Proc Natl Sci USA 86: 4958–4962CrossRefGoogle Scholar
  8. Benko DM, Robinson R, Solomin L, Mellini M, Felber BK, Pavlakis GN (1990) Binding of trans-dominant mutant rev protein of human immunodeficiency virus type 1 to the cis-acting rev-responsive element does not affect the fate of viral mRNA. New Biologist 2:1111–1122PubMedGoogle Scholar
  9. Berns Kl, Bohenzky RA (1987) Adeno-associated viruses: an update. Adv Virus Res 32: 243–306PubMedCrossRefGoogle Scholar
  10. Berns Kl, Pinkerton TC, Thomas GF, Hoggan MD (1975) Detection of adeno-associated virus (AAV)-speeifie nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556–560PubMedCrossRefGoogle Scholar
  11. Bohnlein S, Pirker FP, Hofer L, Zimmermann K, Bachmayer H, Bohnlein E, Hauber J (1991) Trans-dominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol 65: 81–88PubMedGoogle Scholar
  12. Breman JG, Arita I (1980) The confirmation and maintenance of smallpox eradication. N Engl J Med 303: 1263–1273PubMedCrossRefGoogle Scholar
  13. Buonocore L, Rose JK (1990) Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345: 625–628PubMedCrossRefGoogle Scholar
  14. Cameron FH, Jennings PA (1989) Specific gene suppression by engineered ribozymes in monkey cells. Proc Natl Acad Sci USA 86: 9139–9143PubMedCrossRefGoogle Scholar
  15. Cech TR (1988) Ribozymes and their medical implications. J Am Med Assoc 260: 3030–3034CrossRefGoogle Scholar
  16. Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55: 599–629PubMedCrossRefGoogle Scholar
  17. Chang L-J, Stoltzfus CM (1985) Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA. Mol Cell Biol 5: 2341–2348PubMedGoogle Scholar
  18. Chang L-J, Stoltzfus CM (1987) Inhibition of Rous sarcoma virus replication by antisense RNA. J Virol 61:921–924PubMedGoogle Scholar
  19. Chatterjee S, Rose JA, Johnson PR, Wong KK Jr (1991) Transduction of intracellular resistance to HIV production by an adeno-associated virus-based antisense vector. Vaccine 91: 85–90Google Scholar
  20. Cohen EA, Gaudreau P, Brazeau P, Langelier Y (1986) Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature 321:441–443PubMedCrossRefGoogle Scholar
  21. Coleman J, Hirashima A, Inokuchi Y, Green PJ, Inouye M (1985) A novel immune system against bacteriophage infection using complementary RNA (micRNA). Nature 315: 601–603PubMedCrossRefGoogle Scholar
  22. Cotton M, Birnstiel ML (1989) Ribozyme mediated destruction of RNA in vivo. EMBO J 8: 3861–3866Google Scholar
  23. Cukor G, Blacklow NR, Hoggan D, Berns Kl (1984) Biology of adeno-associated virus. In: Berns Kl (ed) The Parvoviruses. Plenum, New York, pp 33–66Google Scholar
  24. Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagensis: integration of proviruses in a distinct chromosomal region. Cell 37:141–150PubMedCrossRefGoogle Scholar
  25. Dalgleish AG, Beverley PCI, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767PubMedCrossRefGoogle Scholar
  26. Domke I, Straub P, Kirchner H (1986) Effect of interferon on replication of herpes simplex virus type 1 and 2 in human macrophages. J Virol 60: 37–42Google Scholar
  27. Dutia BM, Frame MC, Subak-Sharpe JH, Clark WN, Marsden HS (1986) Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature 321: 439–441PubMedCrossRefGoogle Scholar
  28. Eglitis MA, Anderson WF (1988) Retroviral vectors for introduction of genes into mammalian cells. BioTechniques 6: 608–614PubMedGoogle Scholar
  29. Faraji-Shadan F, Stubbs JD, Bowman PD (1990) A putative approach for gene therapy against human immunodeficiency virus (HIV). Med Hypotheses 32: 81–84PubMedCrossRefGoogle Scholar
  30. Feng S, Holland EC (1988) HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334: 165–167PubMedCrossRefGoogle Scholar
  31. Friedman AD, Triezenberg SJ, McKnight SL (1988) Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature 335: 452–454PubMedCrossRefGoogle Scholar
  32. Gao W-Y, Stein CA, Cohen JS, Dutschman GE, Cheng Y-C (1989) Effect of phosphorothioate homooligodeoxynucleotides on herpes simplex virus type 2 induced DNA polymerase. J Biol Chem 264:11521–11526PubMedGoogle Scholar
  33. Gao W-Y, Hanes RN, Vazquez-Padua MA, Stein CA, Cohen JS, Cheng Y-C (1990) Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother 34: 808–812PubMedGoogle Scholar
  34. Goldstein DJ, Weller SK (1988) Factor(s) present in herpes simpJex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology 166: 41–51PubMedCrossRefGoogle Scholar
  35. Goodchild J, Agrawal S, Civiera MP, Sarin PS, Sun D, Zamecnik PC (1988) Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 85: 5507–5511PubMedCrossRefGoogle Scholar
  36. Graham GJ, Maio JJ (1990) RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc. Natl Acad Sci USA 87: 5817–5821PubMedCrossRefGoogle Scholar
  37. Green M, Ishino M, Loewenstein PM (1989) Mutational analysis of HIV-1 tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58: 215–223PubMedCrossRefGoogle Scholar
  38. Green PJ, Pines O, Inouye M (1986) The role of antisense RNA in gene regulation. Annu Rev Biochem 55: 569–97PubMedCrossRefGoogle Scholar
  39. Gresser I (1986) Interferon-induced diseases. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II. Springer, Berlin Heidelberg New York, pp 232–242Google Scholar
  40. Haigh A, Greaves R, O’Hare P (1990) Interference with the assembly of a virus-host transcription complex by peptide competition. Nature 334: 257–259CrossRefGoogle Scholar
  41. Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse al(l) collagen gene by blocking initiation of transcription. Nature 320: 365–367PubMedCrossRefGoogle Scholar
  42. Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585–591PubMedCrossRefGoogle Scholar
  43. Hayward WS, Neel BG, Astrin SM (1981) Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480PubMedCrossRefGoogle Scholar
  44. Helene C, Toulme J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049: 99–125PubMedGoogle Scholar
  45. Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81: 6466–6470PubMedCrossRefGoogle Scholar
  46. Herskowitz I (1987) Functional inactivation of genes by dominant negative mutations. Nature 329: 219–222PubMedCrossRefGoogle Scholar
  47. Jenner E (1798) An inquiry into the causes and effects of the variolae vaccine, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of cowpox. Sampson Low, LondonGoogle Scholar
  48. Jennings PD, Molloy PL (1987) Inhibition of SV40 replicon function by engineered antisense RNA transcribed by RNA polymerase III. EMBO J 10: 3043–3047Google Scholar
  49. Johnson RM, Spear PG (1989) Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J Virol 63: 819–827PubMedGoogle Scholar
  50. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768PubMedCrossRefGoogle Scholar
  51. Kotin RM, Berns Kl (1989) Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170: 460–467PubMedCrossRefGoogle Scholar
  52. Kotin RM, Siniscalco M, Samulski RJ, Zhu X, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns Kl (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211–2215PubMedCrossRefGoogle Scholar
  53. Kulka M, Smith CC, Aurelian L, Fishelevich R, Meade K, Miller P, Ts’o POP (1989) Site specificity of the inhibitory effects of oligo (nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci USA 86: 6868–6872PubMedCrossRefGoogle Scholar
  54. LaFace D, Hermonat P, Wakeland E, Peck A (1988) Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162: 483–486PubMedCrossRefGoogle Scholar
  55. Lebkowski JS, McNally MM, Okarma TB, Lerch LB (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996PubMedGoogle Scholar
  56. Lisziewicz J, Rappaport J, Dhar R (1991) Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biologist 3: 82–89PubMedGoogle Scholar
  57. Malim MH, Bohnlein S, Haubér J, Cullen BR (1989) Functional dissection of the HIV-1 rev trans-activator: derivation of a trans-dominant repressor of rev function. Cell 58: 205–214PubMedCrossRefGoogle Scholar
  58. Mavromara-Nazos P, Ackermann M, Roizman B (1986) Construction and properties of viable herpes simplex virus type 1 recombinant lacking coding sequences of the α47 gene. J Virol 60: 807–812PubMedGoogle Scholar
  59. Mermer B, Felber BK, Campbell M, Pavlakis GN (1990) Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res 18: 2037–2044PubMedCrossRefGoogle Scholar
  60. Mannino RJ, Gould-Fogerite S (1988) Liposome mediated gene transfer. BioTechniques 6: 682–690PubMedGoogle Scholar
  61. McClements W, Yamanaka G, Garsky V, Perry H, Bacchetti S, Colonno R, Stein RB (1988) Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology 162: 270–273PubMedCrossRefGoogle Scholar
  62. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62:1963–1973PubMedGoogle Scholar
  63. Miller AD (1990) Progress toward human gene therapy. Blood 76: 271–278PubMedGoogle Scholar
  64. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242PubMedGoogle Scholar
  65. Miroshnichenko Ol, Ponomareva Tl, Tikchonenko Tl (1989) Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral Ela region. Gene 84: 83–89PubMedCrossRefGoogle Scholar
  66. Mittnacht S, Straub P, Kirschner H, Jacobsen H (1988) Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164: 201–210PubMedCrossRefGoogle Scholar
  67. Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF (1990) Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res Hum Retroviruses 6:183–191PubMedCrossRefGoogle Scholar
  68. Paradis H, Gaudreau P, Brazeau P, Langelier Y (1988) Mechanisms of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. J Biol Chem 263: 16045–16050PubMedGoogle Scholar
  69. Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R (1990) A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat Proc Natl Acad Sci USA 87: 5079–5083PubMedCrossRefGoogle Scholar
  70. Post LE, Roizman B (1981) A generalized technique for deletion of specific genes in large genomes: a gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25: 227–232PubMedCrossRefGoogle Scholar
  71. Powell PA, Stark DM, Sanders PR, Beachy RN (1989) Protection against tobacco mosaic virus in transgenic plants that express tobacco mosaic virus antisense RNA. Proc Natl Acad Sci USA 86: 6949–6952PubMedCrossRefGoogle Scholar
  72. Prody GA, Bakos JT, Buzayan JM, Schneider IR, Bruening G (1986) Autolytic processing of dimeric plant virus satellite RNA. Science 231:1577–1580PubMedCrossRefGoogle Scholar
  73. Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689PubMedCrossRefGoogle Scholar
  74. Rhodes A, James W (1990) Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol 71:1965–1974PubMedCrossRefGoogle Scholar
  75. Rimsky L, Due Dodon M, Dixon EP, Greene WC (1989) Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I rex transactivator. Nature 341: 453–456PubMedCrossRefGoogle Scholar
  76. Salter DW, Crittenden LB (1989) Artificial insertion of a dominant gene for resistance to avian leukosis virus into the germ line of the chicken. Theor Appl Genet 77: 457–461CrossRefGoogle Scholar
  77. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
  78. Sarmiento M, Kleinerman ES (1990) Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication. J Immunol 144(5): 1942–1953PubMedGoogle Scholar
  79. Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA, Rossi JJ (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222–1225PubMedCrossRefGoogle Scholar
  80. Sczakiel G, Pawlita M (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol 65: 468–472PubMedGoogle Scholar
  81. Sears AE, Halliburton IW, Meignier B, Silver S, Roizman B (1985) Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells, and establishment of latency in mice. J Virol 55: 338–346PubMedGoogle Scholar
  82. Seif I, de Maeyer E, Riviere I, de Maeyer-Guignard J (1991) Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment. J Virol 65: 664–671PubMedGoogle Scholar
  83. Shepard AA, Polentino P, DeLuca NA (1990) Trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol 64: 3916–3926PubMedGoogle Scholar
  84. Simons RW, Kleckner N (1988) Biological regulation by antisense RNA in prokaryotes. Annu Rev Genet 22: 567–601PubMedCrossRefGoogle Scholar
  85. Smith CC, Aurelian L, Reddy MP, Miller PS, Ts’o POP (1986) Antiviral effect olan oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc Natl Acad Sci 83: 2787–2791PubMedCrossRefGoogle Scholar
  86. Staeheli P (1990) Interferon-induced proteins and the antiviral state. Adv Virus Res 38: 147–200PubMedCrossRefGoogle Scholar
  87. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C (1986) Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44: 147–158PubMedCrossRefGoogle Scholar
  88. Sullenger BA, Lee TC, Smith CA, Lingers GE, Gilboa E (1990a) Expression of chimeric tRNA-driven antisense transcripts renders NIH3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol 10: 6512–6523PubMedGoogle Scholar
  89. Sullenger BA, Gallardo HF, Lingers GE, Gilboa E (1990b) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608PubMedCrossRefGoogle Scholar
  90. Tratschin JD, West MH, Sandbank T, Carter BJ (1984) A human parvovirus, adeno-associated virus, as a eukaryotic vector: transient expression and encapsidation of the prokaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4: 2072–2081PubMedGoogle Scholar
  91. Trono D, Feinberg MB, Baltimore D (1989) HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59:113–120PubMedCrossRefGoogle Scholar
  92. Van der Krol AR, Lenting PE, Veenstra J, Van der Meer IM, Koes RE, Geräts AGM, Mol JNM, Stuitje AR (1988a) An anti-sense chalcone synthase gene in transgenic plants inhibits flower pigmentation. Nature 333: 866–869CrossRefGoogle Scholar
  93. Van der Krol AR, Mol JNM, Stuitje AR (1988b) Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. BioTechniques 6: 958–976PubMedGoogle Scholar
  94. Von Rüden T, Gilboa E (1989) Inhibition of human T-cell leukemia virus type 1 replication in primary human T cells that express antisense RNA. J Virol 63: 677–682Google Scholar
  95. Walder J (1988) Antisense DNA and RNA: progress and prospects. Genes Dev 2: 502–504PubMedCrossRefGoogle Scholar
  96. Weintraub H, Izant JG, Harland RM (1985) Anti-sense RNA as a molecular tool for genetic analysis. Trends Genet 2: 22–25CrossRefGoogle Scholar
  97. Werge TM, Biocca S, Cattaneo A (1990) Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. FEBS Lett 274:193–198PubMedCrossRefGoogle Scholar
  98. Whitley RJ (1990) Herpes simplex viruses. In: Fields BN, Knipe DM et al. Virology, 2nd edn. Raven, New York, pp 1843–1887Google Scholar
  99. Wong KK Jr, Rose JA, Chatterjee S (1991) Restriction of HSV-1 production in cell lines transduced with an antisense viral vector targeting the ICP4 gene. In: Vaccine 91. Cold Spring Harbor Laboratory Press, New York, pp 183–189Google Scholar
  100. Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transfor-mation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75: 280–284PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1992

Authors and Affiliations

  • K. K. WongJr.
    • 1
  • S. Chatterjee
    • 2
  1. 1.Department of Hematology, Bone Marrow Transplantation ServiceCity of Hope National Medical CenterDuarteUSA
  2. 2.Division of Pediatrics, City of Hope National Medical Center and Department of Molecular GeneticsBeckman Research InstituteDuarteUSA

Personalised recommendations